Purpose: Choosing Wisely (CW) is an emergent approach to identify and reduce unnecessary care, such as tests and treatments that do not add value for patients and may even cause harm. The purpose of this paper is to investigate whether and how Lean Healthcare Management (LHM) can support CW objectives, focusing on customer needs and on waste elimination. Data sources: A systematic literature review has been performed in Scopus, PubMed and Web of Science. Study selection: Peer reviewed articles published in English language have been selected. Papers were considered if they regarded LHM and its possible support for achieving CW objectives.
Introduction
Choosing Wisely (CW) is an initiative of the American Board of Internal Medicine Foundation aimed at helping providers and patients to identify and reduce unnecessary care, such as tests, treatments and procedures that do not add value for patients and may even cause harm [1] . Making smart and effective care choices to reduce harms and wastes requires involving the patient in clinical decisions and choosing care that is supported by evidence, not duplicative of other tests or procedures already received, free from harm and truly necessary, delivering the right care at the right time [2, 3] . Grady and Redberg [4] emphasized that 'Less is More': the overuse of medical care may cause harm, while less care could possibly lead to better health. Moreover, because the resources are finite, the elimination of wasteful and non-beneficial interventions is mandatory from both an ethical and pragmatic point of view [5] . For this reason, physicians at the institutional and organizational level must appropriately allocate scarce resources and scrupulously avoid superfluous tests and procedures [6] . They must be engaged in improving quality and access to care, in fostering a just and costeffective distribution of resources, and in maintaining patient trust and confidence by managing conflicts of interest [7] . This contrasts with defensive medicine and the culture of 'doing something', which are typically adopted to reduce the risk of liability [8] . One of CW's aims is the creation of a 'Top 5 List': a set of the main procedures, treatments and therapies that are commonly practiced and are expensive, and which, based on evidence-based recommendations, do not produce substantial benefits for most of the patients for whom they are commonly prescribed [6] . This method is based on a theory proposed by Brody [5] , who stated that the formulation of a list of the main sources of clinical waste enables the improvement of patient safety by focusing on the utility of therapies, rather than on direct cost containment. In addition to a positive effect on service quality, an analysis of the three lists proposed by the National Physicians Alliance [9] estimates a potential savings of $5 billion through the removal of the identified items.
Several organizations have produced lists of 'Things Providers and Patients Should Question', making evidence-based recommendations to enable wise decisions and to provide the most appropriate care according to individual patient needs [2] . As highlighted by Malhotra et al. [10] and Levinson et al. [1] CW, which began in Canada and the US, is now spreading worldwide, such as in the UK, Japan, Italy, Germany, Switzerland, Australia, Netherlands, Denmark, Wales and Canada, with the aim to improve healthcare quality. Despite CW's impact on decreasing healthcare waste, ethical and economic issues cannot be neglected: although tests that are expensive and of questionable benefit might be commonly defined as 'waste', distinguishing between high and low-value care is complicated, especially in situations in which a therapy can be more or less effective, depending on the individual clinical case [11] . Moreover, the processes for defining lists are not transparent, and in some cases, they are absent [12] : even if the listed therapies are evidence based, the selection of treatments is mostly subjective, and thus, it could overlook real patient needs because of the interests of other stakeholders [5] . Furthermore, physicians have discussed the difficulty of converting the Top 5 List's recommendations into practice due to different patient preferences and a lack of a global consensus with other specialties involved in the same care process [13] . Therefore, to sustain the reduction of activities that add no benefit, it is necessary to develop tools that identify low-value therapies at the point of care [14] . In the literature, no great emphasis has been placed on the approach that should be adopted for the definition and selection of the right care process, the elimination of unnecessary activities and the inappropriate use of scarce resources. Such a focus on value is rooted in Lean Thinking, whose principles, tools and practices have been successfully implemented to improve the quality of care of several hospitals [15, 16] . Despite the absence of a univocal definition of Lean Healthcare Management (LHM), scholars [16, 17] agree that its principles are based on a continuous improvement process by removing 'No Value Added' (NVA) activities, which are defined as 'waste' [18, 19] , and by streamlining care processes to maximize the care value from a patient-centred point of view.
Based on these considerations, to fill the gap in the literature and to support healthcare managers in finding a scientific method for the application of CW, LHM could be selected as a methodology for the detection of overutilization and other wastes in healthcare, supporting the CW purpose. Both these approaches pursue healthcare quality improvement, reducing wastes and leveraging patient value but, probably due to its recent introduction, CW seems to still not have adequate tools and practices and a coherent organization to achieve it in an effective and structured manner. On the contrary, lean management is a managerial methodology scientifically recognized that has been systematically applied also in healthcare to define value, to understand and analyse processes, to solve wastes and errors [20] . Therefore, CW could include principles, tools and practices of LHM. Moreover, the LHM facilitators identified by Andersen et al. [21] could be useful also for CW implementation and they refer to: top management engagement, cultural change, teamworking, staff and patient involvement.
For this reason, the aim of this paper is to examine the potential links between CW and LHM, and in particular, to investigate how LHM can support CW. After describing the research design, the results will be presented, and a discussion will be derived. At the end of the paper, suggestions for future research will be provided.
Research design
Based on the remarks presented in the previous section, the aim is to investigate how LHM and its specific tools and practices can be exploited to pursue CW's objectives. This general aim has been divided into the following research questions:
-Can LHM be adopted to support the achievement of CW's objectives? -If so, how does LHM contribute to the achievement of CW's objectives?
To achieve the purpose of the paper, a systematic literature review has been accomplished based on the PRISMA guidelines [22, 23] . In order to find relevant articles concerning the above-mentioned questions, during March 2014, a search of three scientific databases was performed using keywords derived from Lean Management and CW (Fig. 1) . The selection of the papers was performed following the five steps detailed in Fig. 1 ; it produced a database composed of 16 papers that provided a significant contribution toward answering the research questions.
After a descriptive analysis of the database, each paper was studied considering its objectives, methods and results. The analysis of the papers was carried out focusing first on the definition of CW and then categorizing the papers into different CW objectives and diverse purposes for LHM adoption to resolve the issues addressed by CW; furthermore, CW and LHM tools and practices were identified. The authors worked independently on the categorization of the papers and discussed any disagreements.
Results and discussion
Although the selected papers are not numerous, they appear to be authoritative, because all the journals in which they were published have high scores for Impact Factor (Web of Science) or Scimago Journal Rank Indicator (Scopus) ( Table 1) .
A variety of authors and journals are reported in the database, and thus it is not possible to identify experts or a leading journal on the theme under consideration. The topic's novelty is confirmed by the lack of articles prior to 2007 and by 69% of the papers published after 2011. As far as the field of application is concerned, the most studied wards were laboratories and oncology.
An analysis of the countries addressed in the papers reveals that more than half of the studies were conducted in the USA (63%), followed by the Netherlands (19%), which together, comprise nearly the entire database (82%).
CW's motivations and objectives
The main motivations underlying the analysed research are the rising cost of general healthcare or of specific wards or processes, and the variability of the cost, which is attributable to the heterogeneity of clinical cases (e.g. [24] [25] [26] [27] [28] ); other studies were triggered by several peculiar types of waste that had been identified in the interested field of application [29, 30] . From the clinical perspective, questionable tests or utilization of treatment [31] [32] [33] are other motivations for considering CW and LHM together. Several authors highlighted the need to reduce diagnostic tests [24] and follow-ups by assessing their real benefit [34] . Also, treatment options involving different dosages affect ward expenditures and clinical outcomes, and thus, they require further in-depth analysis [35] .
Furthermore, patient safety played a central role in these studies; specifically, they raised the need to reduce ward infections [36] , harm to patients due to therapies that were not evidence-based [37] and avoidable deaths [27] . Only one paper [30] underlined the ethical issues involved in the 'fair' utilization of healthcare resources, both from an economic and clinical point of view.
CW's objectives ( Fig. 2 ) confirm the alignment between CW and the need to assure the appropriateness of care. The latter has been defined as 'the outcome of a process of decision-making that maximizes net individual health gains within society's available resources' [38] . Also, according to Lavis and Anderson [39] , this concept is associated with the effectiveness of a service for a type of patient; therefore, appropriateness is achieved when the symptoms, physical findings and results of diagnostic tests indicate that the patient has benefited from the service received. Appropriateness exists when the expected health benefit exceeds the expected negative consequences by a sufficiently wide margin, which means that the procedure is worth performing [40] . For that reason, appropriateness primarily addresses effectiveness, although the assessment of this dimension is 
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The first 4 searches were performed in "all the fields" in PubMed and Scopus and in the "topic" in WoS Being Scopus a database larger than the others, the last two broader searches were conducted limiƟng the search fields to "ArƟcle Ɵtle, abstract, keywords" In Scopus, all the papers referring to Physical Sciences were excluded, reducing the database from 1311 arƟcles to 1177 papers not straightforward and requires complex steps to be carried out that are aligned with the principles of evidence-based healthcare [41] . In addition to effectiveness, WHO [41] identified efficiency among the dimensions of appropriateness, measuring it as effectiveness per unit of cost. Therefore, a care service is efficient if it is costeffective. The level of importance that should be attributed to this variable, compared to the others, is controversial, but it is linked to the fact that not all effective care services can be provided due to scarce resources; thus, the most cost-effective care must be chosen. Consequently, among different treatments with equal clinical benefits, the one with the lowest cost should be preferred.
STEP 4 CRITERIA OF EXCLUSION
The third dimension of appropriateness considered by WHO [41] was ethical principles and priority setting (e.g. human dignity, equal rights for all, solidarity [42] ). Summing up, appropriate care is delivered whenever there is evidence that it is effective and costeffective [41] .
The recognized objectives of CW in the analysed literature primarily addressed the need to reduce the overuse of resources, concerning, for example, antibiotic use [36] , over screening and overtreatment [29] , unnecessary tests [31, 32, 34] or both of the latter two issues [24, 33, 43] . Another aim of CW is to avoid the delivery of care that is inadequate to address patient needs, and instead, With 'hospital', papers that adopted LHM approach for one or more hospital units were included. to promote evidence-based treatment in order to assure the effectiveness of care [27, 37] . In accordance with the definition of appropriateness, the other two CW objectives are: making effective care choices and cost-effective care choices as shown in Fig. 2 .
Links between LHM's purposes and CW's objectives
In the selected papers, LHM tools and practices are primarily adopted to analyse the steps of the patient process in order to identify problems and tackle them (e.g. [31] ). The main purpose for LHM adoption concerns the optimization of the care process (Fig.  2) . In particular, the aim is to design and implement improved care pathways [44] , to eliminate wastes [24, 29] , including NVA therapies, to simplify the process and put the patient at the centre [30] . Optimizing the process also means streamlining it and achieving improvements in efficiency by reducing the waste of scarce resources [25, 27] . In other cases, LHM is used to optimize the specimen process and to avoid negatively affecting patient care by providing the wrong test at the wrong time [26] .
In Ng [32] , LHM was useful to measure takt-time in order to control laboratory processes, and in Rajan et al. [25] it was adopted to evaluate the process of transactional research. In another three cases, LHM facilitated the comparison of different procedures, tests and processes to choose the best solution, in terms of efficiency and effectiveness [28, 34, 35] .
LHM has been adopted to understand and optimize the process under analysis for the final aim of reducing the overuse of resources (Fig. 2) . One frequent practice is the identification and the classification of waste as a means of recognizing unnecessary testing, procedures and controls that are due more to defensive medicine, lack of knowledge, and uncertainties than to real needs [43] . Several authors have asserted the need to eliminate NVA therapies to prevent harm due to treatment overutilization [26, 31] . In these cases, improvements in communication and cultural changes offered by LHM are considered essential for healthcare strategies designed to meet safety requirements. In the papers in which LHM tools and practices have been adopted for the evaluation and control of processes, CW's goal is to achieve care effectiveness and EBC and to choose the best solution, evaluating diverse alternatives. LHM tools for the understanding, optimization and comparison of processes are used to support cost-effective care choices.
LHM tools, practices and interventions supporting CW
The main LHM tools and practices have been identified for each link between LHM's purposes and CW's objectives (Table 2) . Burkitt et al. [36] adopted LHM techniques to define process criticalities, identify evidence-based practices and publish specific guidelines. Martens et al. [44] analysed the process through 'Present and Future State Maps', defining benchmark-optimized diagnostic pathways, identifying bottlenecks and outlining action plans. In three cases [31, 36, 44] , process understanding is considered the purpose for LHM adoption, as well as process optimization.
Montesarchio et al. [30] , with the intention of promoting a patient-centred culture and compliance with the principles of evidence-based medicine (EBM), suggested the adoption of LHM to reduce NVA therapies in oncology, allowing streamlined healthcare processes and simultaneously preventing human errors and complications due to inappropriate services.
Other interventions with the aim of reducing overuse were reported in four papers [24, 25, 29, 33] . In particular, in Vegting et al. [24] visual management tools reporting the costs of diagnostic tests were reported, while other LHM tools were suggested by Venkatesh and Schuur [33] , who introduced a 'Top 5 List' of procedures to be avoided in emergency medicine to reduce inadequate medical practices.
In Bentley et al. [29] , LHM was recognized as a best practice primarily for identifying and removing operational wastes, particularly NVA activities, but it was also suggested to identify low-value care and to choose the most cost-effective solution. Also, Biffl et al. [27] implemented LHM methodology to manage risk through the prophylaxis of venous thromboembolism with the aim of identifying the best cost-effective care, and they provided internal standards for treatment with low molecular weight heparin. They utilized several LHM tools (e.g. Rapid Improvement Events, value stream analysis, ANDON, A3, Root Cause Analysis, Poka Yoke).
Through process mapping and the subsequent assessment of internal expenditures, Dundas et al. [28] introduced a new tool for the diagnosis of respiratory disease in paediatric wards which allowed the reduction of NVA services and the improvement of diagnostic efficacy. Riley et al. [35] , using process maps and 'spaghetti charts', identified the least expensive practice among three transfusion procedures that have been proven to be equally effective in terms of care quality and patient safety.
Lim et al. [34] performed kaizen events and process mapping to formulate guidelines for physicians to identify and reduce unnecessary cell workups in a laboratory.
Finally, several papers have studied specific solutions to perform cost-benefit analyses of the dispensed therapies, supporting the choice of cost-effective care.
Limitations and directions for future research
The adoption of LHM to support CW is explicitly demonstrated through the analysis of the linkages shown in Fig. 2 ; the limited number of studies found in the literature emphasizes that the adoption of LHM to facilitate the implementation of CW provides an opportunity for further investigation. To this extent, the performed literature review should be updated including papers that will be published in the future; however, based on the current results, it is possible to state that a systematic utilization of LHM is required for waste reduction, process improvement and in support of clinical decisions. According to Shortell et al. [45] , evidence-based management (EBMgt) should identify the organizational strategies, structures and change management practices needed to provide EBM, which is defined as an approach for the identification of the most effective therapies. LHM is proposed as the main reference model, not only to reduce administrative and operational waste but also clinical waste.
In the analysed papers, the cultural and organizational aspects that enable LHM are scarcely investigated: only few practices are reported. The literature regarding LHM and its support to CW provides some tools and techniques to be adopted, but it neglects the soft sociotechnical enablers that should be considered in an integrated approach to guarantee the sustainability and the continuous improvement of the managerial and organizational solutions adopted for quality enhancement [16] . Further research is needed for investigating and valorizing the principles, tools, practices and organizational aspects of LHM, which could be fundamental also for CW implementation. In the papers examined, the application of LHM has primarily led to positive outcomes in terms of the adoption of evidence-based therapies and the elimination of improper treatment. In the future, the application of LHM for the understanding, evaluation and improvement of clinical processes seems likely to increase. Authors in the analysed database called for a more consistent and structured adoption of LHM for clinical services. LHM, combined with comparative effectiveness research (CER) (the analysis of different therapeutic procedures to compare clinical risks, benefits, and the costs of treatment), is also a good topic for future in-depth studies.
In research addressing LHM and CW, the effectiveness of service delivery should be a focus. As Radnor and Osborne [46] stated, instead of utilizing a product-dominant logic and seeking the improvement of internal efficiency alone, the customer should be continuously involved in the process of value creation. Although CW was born with the aim of encouraging collaboration between health providers and patients, tools for such collaboration do not seem to have been adopted and the patient point of view in the analysed papers is not emphasized. As stressed by Malhotra et al. [10] , physician consultation and communication skills, together with new decision aids, should be developed to increase patient involvement in the clinical decision-making process. Based on the public management literature, it is inadequate to identify NVA activities without continuous and strong patient involvement. LHM that supports CW from the health provider perspective alone means the consideration of the scientific-technical dimension of healthcare quality [47] ; this complies with EBM, but neglects the interpersonal processes that characterize healthcare services. The CW experiences suggest that patient associations, as well as doctors, should be involved in the multidisciplinary teams that are assigned to define the top 5 lists in healthcare settings. Therefore, in the adoption of LHM to achieve CW's objectives, patients should contribute to both the understanding and the evaluation of processes and to the comparison and choice of the best solutions, together with physicians.
To sum up, future research should be carried out regarding the adoption of LHM in support of CW, particularly regarding:
• LHM for clinical waste reduction, process improvement and clinical decisions; • LHM as a strategy for clinical practice management, especially as an EBMgt methodology, and considering LHM principles and enabling factors, in addition to tools and practices; • LHM to assess clinical processes; • LHM and CER;
• Patient involvement in service value definition, and thus, in waste elimination and improvements in the clinical decision-making process.
Moreover, other quality management approaches can be considered to support CW, in addition to or in combination with LHM [48] .
Conclusion
To respond to the defined research questions, LHM is adopted to achieve the objectives of CW, assuring appropriate care to patients. First, LHM is used to reduce overuse, but also to assure the effectiveness of care and EBC. Of course, LHM cannot solve all the issues regarding CW and the healthcare quality in general; however, it can help to facilitate CW through process understanding, optimization, evaluation and control, but also through the comparison of alternatives and the choice of the best solution in terms of effectiveness and efficiency. Despite the small size of the sample, the implications of the study are a matter of interest for healthcare stakeholders. From an academic standpoint, this is a new research topic, which advances future research in the process management field. The synergetic implementation of LHM and CW could equip physicians with transparent and reliable decision-making tools, assuring the integration of EBM and EBMgt, as well as a clinical 'safe harbour' from defensive medicine concerns. Furthermore, hospital managers and local and national administrators should promote business process management strategies such as LHM to eliminate NVA activities and treatments in order to achieve a fairer, more equitable and more transparent redistribution of resources, advantaging patients and society in general.
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